Eris Lifesciences Board Meeting on July 29, 2026 for Financial Results

Eris Lifesciences Ltd has announced that its Board of Directors will convene on July 29, 2026. The primary agenda item for this meeting is to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The company also noted that the trading window, which commenced on July 1, 2026, will remain closed until 48 hours after the declaration of these financial results, in compliance with SEBI regulations.